Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)
China · Delayed Price · Currency is CNY 28.12
-0.93 (-3.20%)
At close: Jun 2, 2026
SHE:301509 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 74.03 | 104.81 | 38.61 | 173.57 | 161.45 | 84.55 |
Depreciation & Amortization | 61.93 | 61.93 | 67.43 | 68.1 | 53.94 | 44.54 |
Other Amortization | 0.63 | 0.63 | 0.16 | 0.17 | 0.16 | 0.33 |
Loss (Gain) From Sale of Assets | - | - | 0.61 | 0.49 | - | -0.03 |
Asset Writedown & Restructuring Costs | 1.82 | 1.82 | 4.07 | 0.36 | 7.15 | 7.67 |
Loss (Gain) From Sale of Investments | -23.59 | -23.59 | -19.46 | -4.75 | 0.36 | 0.04 |
Stock-Based Compensation | - | - | - | - | - | 1.86 |
Provision & Write-off of Bad Debts | 2.11 | 2.11 | -1.94 | 3.06 | - | 0.86 |
Other Operating Activities | 22.66 | 21.93 | 13.78 | 11.64 | -6.63 | 3.89 |
Change in Accounts Receivable | -237.37 | -237.37 | -42.46 | -97.28 | -60.58 | -35.7 |
Change in Inventory | 42.7 | 42.7 | 9.88 | 5.24 | -61 | -50.65 |
Change in Accounts Payable | 188.51 | 188.51 | 85.48 | -10.37 | 142.4 | 13.24 |
Change in Other Net Operating Assets | 4.86 | 4.86 | 5.86 | 5.37 | 5.58 | - |
Operating Cash Flow | 140.15 | 170.2 | 154.9 | 155.16 | 241.55 | 72.27 |
Operating Cash Flow Growth | 10.72% | 9.88% | -0.17% | -35.77% | 234.23% | -31.86% |
Capital Expenditures | -49.48 | -41.84 | -54.1 | -72.9 | -126.69 | -170.66 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.5 | 0.78 | 0.01 | 0.33 |
Investment in Securities | 73.78 | 85.79 | -338.07 | 931.01 | -104.75 | - |
Other Investing Activities | 62.47 | 20.41 | 15.77 | -1,797 | - | - |
Investing Cash Flow | 86.8 | 64.39 | -375.9 | -937.99 | -231.42 | -170.32 |
Short-Term Debt Issued | - | - | - | 5 | 32.34 | - |
Long-Term Debt Issued | - | - | - | - | 79.74 | 69.96 |
Total Debt Issued | - | - | - | 5 | 112.08 | 69.96 |
Short-Term Debt Repaid | - | - | -5 | -81.93 | - | -32.34 |
Long-Term Debt Repaid | - | -1.93 | -1.91 | -2.1 | -72.09 | -75.45 |
Total Debt Repaid | -1.93 | -1.93 | -6.91 | -84.04 | -72.09 | -107.79 |
Net Debt Issued (Repaid) | -1.93 | -1.93 | -6.91 | -79.04 | 39.99 | -37.82 |
Issuance of Common Stock | - | - | - | 1,130 | - | 105 |
Common Dividends Paid | -48.37 | -48.37 | -69.15 | - | -4.11 | -49.47 |
Other Financing Activities | - | - | - | -13.45 | -6.18 | -5 |
Financing Cash Flow | -50.3 | -50.3 | -76.06 | 1,037 | 29.7 | 12.7 |
Foreign Exchange Rate Adjustments | -11.11 | -4.73 | 1.34 | 1.25 | 10.13 | -2.31 |
Net Cash Flow | 165.54 | 179.56 | -295.72 | 255.89 | 49.96 | -87.66 |
Free Cash Flow | 90.67 | 128.36 | 100.8 | 82.26 | 114.86 | -98.39 |
Free Cash Flow Growth | 3.79% | 27.34% | 22.54% | -28.39% | - | - |
Free Cash Flow Margin | 14.84% | 20.08% | 20.28% | 10.73% | 16.03% | -17.91% |
Free Cash Flow Per Share | 0.76 | 1.06 | 0.83 | 0.82 | 1.27 | -1.10 |
Cash Interest Paid | - | - | - | 2.2 | - | - |
Cash Income Tax Paid | 16.68 | 16.95 | 13.52 | 8.9 | 5.81 | -3.52 |
Levered Free Cash Flow | 636.84 | 89.81 | 980.72 | -877.86 | 53.95 | -191.05 |
Unlevered Free Cash Flow | 636.95 | 89.93 | 980.92 | -876.48 | 55.64 | -189.5 |
Change in Working Capital | 0.56 | 0.56 | 51.65 | -97.49 | 25.12 | -71.45 |